Atherosclerosis is a key mechanism underlying the pathogenesis of cardiovascular disease,
which is associated with high morbidity and mortality. In the field of precision medicine for …

Current advances in nanotechnology have paved the way for the early detection, prevention
and treatment of various diseases such as vascular disorders and cancer. These advances …

A large majority of cardiovascular nanomedicine research has focused on fabricating
designer nanoparticles for improved targeting as a means to overcome biological barriers …

Atherosclerosis is a typical chronic inflammatory vascular disease that seriously endangers
human health. At present, oral lipid‐lowering or anti‐inflammatory drugs are clinically used …

Nanomaterial-based drug delivery systems (NBDDS) are widely used to improve the safety
and therapeutic efficacy of encapsulated drugs due to their unique physicochemical and …

Cardiovascular diseases are widely prevalent in western societies, and their associated
costs number in the billions of dollars and affect millions of patients each year. Nanovectors …

Atherosclerosis is the root of approximately one‐third of global mortalities. Nanotechnology
exhibits splendid prospects to combat atherosclerosis at the molecular level by engineering …

Nanoparticles have been investigated as promising nanocarriers for delivery of imaging and
therapeutic agents for several decades, but have met with limited success. Although …

Cardiovascular diseases (CVDs) remain one of the major causes of mortality worldwide. In
response to this and other worldwide health epidemics, nanomedicine has emerged as a …

Cardiovascular disease (CVD) is comprised of a group of disorders affecting the heart and
blood vessels of the human body and is one of the leading causes of death worldwide …